Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era
Table 2
Clinical features and outcome of combined retinal detachment.
Case
Left/right eye
Extent of RD (quadrant)
Severity of vitreoretinal adhesion (grade)
Vascular component of proliferative tissue (chronic fibrotic versus active fibrovascular proliferative)
Retinal breaks found preop. or not
Number of retinal breaks (single versus multiple breaks)
Preop. VA (logMAR)
Post-op. VA (logMAR)
Complication
1
L
3
3
Chronic
−
Multiple
2
1.5
—
2
R
2
2
Active
−
Multiple
1.7
0.7
RAO
3
L
4
4
Active
−
Multiple
HM/20 cm
CF/20 m
Foveal atrophy
4
R
3
1
Active
+
Multiple
HM/1 m
1.7
—
5
L
3
3
Chronic
+
Multiple
2
0.7
—
6
L
2
3
Active
−
Multiple
2
1
—
R
4
4
Chronic
+
Multiple
HM/1 m
NLP
NVG
7
L
3
2
Chronic
+
Multiple
CF/70 cm
1
—
8
R
1
1
Chronic
+
Multiple
1
0.3
Recurrent VH
9
L
2
4
Chronic
+
Multiple
CF/30 cm
1.3
—
10
R
1
1
Active
−
Single
0.7
0.22
—
11
R
2
2
Active
+
Multiple
1.5
0.52
NVG
12
L
3
2
Chronic
+
Single
1.3
1.4
—
13
L
4
4
Chronic
−
Single
1.3
0.82
—
14
R
3
3
Active
−
Single
1.3
1
—
15
R
2
4
Chronic
−
Single
HM/30 m
1.52
—
16
L
3
4
Chronic
+
Single
HM/1 m
0.7
ERM
17
L
3
4
Chronic
−
Multiple
0.52
1.3
Foveal atrophy
R
1
1
Chronic
+
Single
1.7
1
—
18
R
3
3
Active
+
Single
1.7
0.52
—
19
R
4
3
Chronic
+
Single
CF/30 cm
1.3
—
L
4
3
Active
−
Multiple
HM/50 cm
HM/1 m
—
20
R
4
3
Active
−
Single
CF/20 cm
0.7
—
21
R
2
3
Chronic
−
Multiple
0.7
0.82
—
22
L
2
2
Active
+
Single
0.82
0.52
Recurrent VH, RAO
23
L
3
3
Active
−
Single
2
1
ERM
24
R
2
4
Active
−
Multiple
2
1.7
—
25
L
4
3
Active
−
Multiple
HM/30 cm
0.7
—
26
R
1
3
Active
+
Multiple
0.52
0.22
—
L
3
3
Active
+
Single
1.7
0.82
NVG
27
R
2
2
Active
−
Multiple
2
1
—
28
R
4
3
Active
−
Single
CF/60 cm
CF/60 cm
—
29
R
4
4
Active
−
Single
2
HM/40 cm
NVG
30
R
2
2
Chronic
−
Single
2
1.3
—
31
L
4
3
Active
+
Single
HM/1 m
1.3
—
32
L
4
4
Active
+
Multiple
HM/10 cm
HM/30 cm
—
33
R
3
3
Active
+
Single
1.7
1.3
—
L
3
3
Active
−
Multiple
CF/50 cm
1
—
34
L
4
4
Chronic
−
Multiple
CF/30 cm
1.3
—
35
L
2
2
Active
−
Single
2
0.7
—
R
2
2
Active
−
Multiple
0.4
0.82
ERM
36
L
2
2
Active
+
Multiple
HM/1 m
1.7
—
37
L
4
1
Chronic
−
Multiple
1.7
1
—
38
R
3
4
Active
−
Multiple
1.7
1.52
—
39
R
1
2
Active
−
Multiple
1.52
1.7
—
40
R
2
2
Active
+
Multiple
CF/50 cm
0.52
—
41
L
4
1
Chronic
+
Single
HM/50 m
CF/60 cm
—
42
L
4
2
Chronic
+
Multiple
CF/20 cm
1.7
—
43
L
4
3
Active
−
Single
HM/1 m
0.82
—
44
R
3
3
Chronic
+
Multiple
HM/60 cm
1.3
—
45
L
2
3
Chronic
−
Single
1.5
0.82
ERM
R
1
3
Active
−
Single
1.3
0.7
—
46
R
4
3
Chronic
+
Single
1.7
1.3
—
L
4
3
Chronic
+
Single
1.3
0.7
—
47
R
2
3
Active
−
Single
0.7
0.22
—
48
R
4
3
Active
+
Multiple
HM/1 m
CF/40 cm
—
49
R
2
2
Chronic
+
Single
1.6
0.82
—
CF: counting fingers; ERM: epiretinal membrane; HM: hand motion; NLP: nonlight perception; NVG: neovascular glaucoma; RAO: retinal artery occlusion; VH: vitreous hemorrhage. The severity of vitreoretinal adhesion was defined as multiple-point adhesions with or without 1-site-wide plaque-like adhesion (Grade 1), broad adhesions in more than 1 but fewer than 3 sites posterior to equator (Grade 2), broad adhesions in more than 3 sites posterior to equator or 1 site anterior to equator (Grade 3), and broad adhesions more than 1 site anterior to equator (Grade 4).
